Top Markets
Coin of the day
Biostage, Inc. Biostage, Inc.

Biostage, Inc.

BSTG
Rank in Stocks #24986
Biostage, Inc. is a biotechnology enterprise dedicated to developing medical... Biostage, Inc. is a biotechnology enterprise dedicated to developing medical products aimed at curing patients suffering from cancers, injuries, and congenital defects within the gastrointestinal system and respiratory pathways. A primary focus for the company is the advancement of its Biostage Esophageal Implant, specifically designed to address esophageal cancer. Founded in 2009, the organization was formerly known as Harvard Apparatus Regenerative Technology, Inc. before rebranding as Biostage, Inc. in March 2016. Its corporate headquarters are located in Holliston, Massachusetts.
Share Price
$3.95
Last synced: 2023-08-15
Market Cap
$54.45M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Biostage, Inc. (BSTG)

Category

P/B ratio for Biostage, Inc. (BSTG)
P/B ratio as of 2026 TTM: 0
According to Biostage, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Biostage, Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH
3.7087 -
US